AESEG - Medicamentos genéricos

Did you know?
A generic and a branded medicine have the same active substance and, therefore, they are interchangeable »
A generic medicine has the same quality, efficacy and safety as the original product »
Generic medicines can reduce the price of an innovator product up to 60% »
Generic medicines cost less because there has been no investment to discover them »
The first generic medicine commercialised in Spain was the AZT or Zidovudina for the treatment of HIV »
The use of generic medicines in the National Public Health departments is increasing »
You differentiate a generic because it has the name of the active substance and the letters EFG on its label »
Versión EspañolaRSS

Generic medicines in the European Union

  • Print

Generic medicines participation in the total pharmaceutical market, either in volume or in value, positions Spain far away from the European average. The following charts clearly show the strong impact in health savings when there is a strong penetration of generic medicines. According to the latest data from the European Generic Medicines Association (EGA), the United Kingdom saves up to 6.000 million Euros per year.

Generic medicines market quota in the European Union

Source: EGA (European Generic Medicines Association)

Annual savings generated by generic medicines in the European Union

Source: EGA (European Generic Medicines Association)

You are here: Home Generics Generic medicines in the European Union

 

 



Generic Medicines EFG
Twitter
Spanish Generic Medicines Association
New address
Velázquez, 54 - 3º
28001 - Madrid - España
T. +34 91 572 12 62
F. +34 91 571 34 20


European Generic Medicines Association
Linkedin


Spanish Agency of Medicines and Sanitary Products
RSS